Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Review
New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 16,140 | Dovepress* | 13,126+ | 1,347 | 14,473 | |
| PubMed Central* | 3,014 | 794 | 3,808 | ||
| Totals | 16,140 | 2,141 | 18,281 | ||
| *Since 16 July 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 18 | 0 | 0 | 0 | 9 | 9 |
View citations on PubMed Central and Google Scholar